Free Trial

Aspen Pharmacare (APNHY) Stock Price, News & Analysis

0.00 (0.00%)
(As of 05/21/2024 ET)
Today's Range
50-Day Range
52-Week Range
1 shs
Average Volume
300 shs
Market Capitalization
$5.62 billion
P/E Ratio
Dividend Yield
Price Target
APNHY stock logo

About Aspen Pharmacare Stock (OTCMKTS:APNHY)

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

APNHY Stock Price History

APNHY Stock News Headlines

Aspen Pharmacare Holdings Ltd. ADR
Aspen Pharmacare Holdings Ltd (APNJ)
Aspen High School
Getting Around Aspen
See More Headlines
Receive APNHY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aspen Pharmacare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Fiscal Year End

Industry, Sector and Symbol

Private households
Current Symbol
Previous Symbol
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
$2.30 billion
Cash Flow
$1.07 per share
Book Value
$10.90 per share


Free Float
Market Cap
$5.62 billion
Not Optionable
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Stephen Bradley Saad BCom (Age 60)
    CA(SA), Group CEO & Executive Director
    Comp: $1M
  • Mr. Sean M. Capazorio (Age 57)
    Group CFO & Executive Director
    Comp: $546.46k
  • Ms. Lorraine Hill (Age 60)
    Group Chief Operations Officer & Responsible Pharmacist
    Comp: $588.92k
  • Mr. Michael Guy Attridge B.Com. (Age 63)
    CA(SA), Group Chief Advisor
    Comp: $443.03k
  • Mr. Reginald Haman Grad. Dip. (Age 49)
    MBA, ND, NHD, PGDBA, Group Chief Corporate Services Officer & Executive Director
    Comp: $412.23k
  • Ms. Zizipho Mmango (Age 39)
    Group Chief Strategic Development Officer
    Comp: $412.18k
  • Sibongakonke Nkosi
    Investor Relations Manager
  • Mr. Trevor Julian Ziman (Age 52)
    Regional Chief Executive Officer of Asia Pacific
  • Mr. Samer Kassem (Age 49)
    Chief Executive Officer of Aspen Global Incorporated
  • Ms. Raeesa Khan
    Group Company Secretary

APNHY Stock Analysis - Frequently Asked Questions

How have APNHY shares performed in 2024?

Aspen Pharmacare's stock was trading at $10.97 at the start of the year. Since then, APNHY stock has increased by 14.8% and is now trading at $12.5950.
View the best growth stocks for 2024 here

Are investors shorting Aspen Pharmacare?

Aspen Pharmacare saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 1,200 shares, a decline of 64.7% from the March 31st total of 3,400 shares. Based on an average daily volume of 200 shares, the short-interest ratio is currently 6.0 days.
View Aspen Pharmacare's Short Interest

How often does Aspen Pharmacare pay dividends? What is the dividend yield for Aspen Pharmacare?

Aspen Pharmacare declared a dividend on Thursday, September 21st. Investors of record on Friday, September 22nd will be given a dividend of $0.1297 per share on Wednesday, October 11th. The ex-dividend date is Thursday, September 21st.
Read our dividend analysis for APNHY

Is Aspen Pharmacare a good dividend stock?

Aspen Pharmacare (OTCMKTS:APNHY) pays an annual dividend of $0.13 per share and currently has a dividend yield of 1.00%.
Read our dividend analysis for APNHY.

How do I buy shares of Aspen Pharmacare?

Shares of APNHY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:APNHY) was last updated on 5/22/2024 by Staff

From Our Partners